Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ReposiTrak (TRAK) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for ReposiTrak (TRAK) over the last 12 years, with Q3 2025 value amounting to $19.1 million.

  • ReposiTrak's Shares Outstanding (Diluted Average) rose 14.66% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 14.66%. This contributed to the annual value of $19.1 million for FY2025, which is 110.93% up from last year.
  • ReposiTrak's Shares Outstanding (Diluted Average) amounted to $19.1 million in Q3 2025, which was up 14.66% from $19.1 million recorded in Q2 2025.
  • ReposiTrak's 5-year Shares Outstanding (Diluted Average) high stood at $19.9 million for Q1 2021, and its period low was $18.7 million during Q4 2022.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $19.2 million, with a median of $19.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first tumbled by 510.11% in 2022, then soared by 170.55% in 2024.
  • ReposiTrak's Shares Outstanding (Diluted Average) (Quarter) stood at $19.7 million in 2021, then fell by 5.1% to $18.7 million in 2022, then increased by 0.77% to $18.8 million in 2023, then rose by 1.71% to $19.1 million in 2024, then fell by 0.07% to $19.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $19.1 million in Q3 2025, compared to $19.1 million in Q2 2025 and $19.1 million in Q1 2025.